On June 20, 2025, Aptevo Therapeutics Inc. filed a prospectus supplement to offer up to $8,037,381 worth of common stock under an existing agreement, having already raised $3,765,143 from previous sales. This filing does not constitute an offer to sell or solicit offers to buy the shares.